Med. praxi. 2023;20(2):104-110 [Urol. praxi. 2021;22(2):70-74]

Modern trends in prophylaxis of lower urinary tract infections

MUDr. Hana Musilová, MUDr. Roman Staněk
Urologické oddělení, Slezská nemocnice v Opavě

Urinary tract infections are very frequent diagnose among bacterial infections. Illness mostly affect women than men (20:1). Prophylaxis lower urinary tract infections is provided by antimicrobial or non-antimicrobial ways. Regarding to increased antibiotics resistance of bacterial strains, modern medicine tend to looking for new non-antimictobial ways of prophylaxis of lower urinary tract infections and decrease frequency of using antibiotic therapy.

Keywords: uroinfection, vulvovaginal discomfort, cranberries, D-mannose, hyaluronic acid, probiotics, immunostimulation, enzymatic therapy.

Published: May 10, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musilová H, Staněk R. Modern trends in prophylaxis of lower urinary tract infections. Med. praxi. 2023;20(2):104-110.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Beneš J, et al. Infekční lékařství. 1.vyd. Praha: Galén; 2009. ISBN 978-80-7262-644-1.
    2. Halaška M, et al. Urogynekologie. 1.vyd. Praha: Galén; 2004. ISBN 90-7262-272-2.
    3. Aydin A, Ahmed K, Zaman I, et al. Recurrent urinary tract infections in women. Int Urogynecol J. 2015 Jun;26(6):795-804. doi: 10.1007/s00192-014-2569-5. Epub 2014 Nov 20. PMID: 25410372. Go to original source... Go to PubMed...
    4. Poršová M, Kolombo I, Porš J, et al. Možnosti prevence recidivujících infekcí močových cest. Urol. praxi. 2006;5:204-209.
    5. Zámečník L, et al. Moderní farmakoterapie v urologii. 1.vyd. Praha: Maxdorf; 2019. ISBN 978-80-7345-609-2.
    6. Špaček J, Buchta V, Jílek P, et al. Vulvovaginální dyskomfort a poruchy poševního prostředí. 1. vyd. Praha: Grada; 2013. ISBN 978-80-247-4554-1.
    7. Čepický P. Vulvovaginitidy pro urogynekology. Urol. praxi. 2018;19(3):111-11. Go to original source...
    8. González de Llano D, Moreno-Arribas MV, Bartolomé B. Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations. Molecules. 2020 Aug 1;25(15):3523. doi: 10.3390/molecules25153523. PMID: 32752183; PMCID: PMC7436188. Go to original source... Go to PubMed...
    9. [Internet] Bonkat G, Bartoletti R, Bruyère F, et al. EAU Guidelines on Urological Infections, European Association of Urology 2021. Available from: http://www.uroweb.org/.
    10. Franssen M, Cook J, Robinson J, et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open. 2021 Jan 13;11(1):e037128. doi: 10.1136/bmjopen-2020-037128. PMID: 33441350; PMCID: PMC7812098. Go to original source... Go to PubMed...
    11. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014 Feb;32(1):79-84. doi: 10.1007/s00345-013-1091-6. Epub 2013 Apr 30. PMID: 23633128. Go to original source... Go to PubMed...
    12. Iavazzo C, Athanasiou S, Pitsouni E, et al. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol. 2007 Jun;51(6):1534-40; discussion 1540-1. doi: 10.1016/j.eururo.2007.03.020. Epub 2007 Mar 20. PMID: 17383810. Go to original source... Go to PubMed...
    13. Goddard JC, Janssen DAW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J. 2018 Jul;29(7):933-942. doi: 10.1007/s00192-017-3508-z. Epub 2017 Nov 27. PMID: 29181550; PMCID: PMC6004275. Go to original source... Go to PubMed...
    14. Solař S. Prebiotika a probiotika v klinické praxi. Med. praxi. 2010;7(1):14-18.
    15. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015 Dec 23;2015(12):CD008772. doi: 10.1002/14651858.CD008772.pub2. PMID: 26695595; PMCID: PMC8720415. Go to original source... Go to PubMed...
    16. Brodie A, El-Taji O, Jour I, et al. A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections. Curr Urol. 2020 Oct;14(3):130-134. doi: 10.1159/000499248. Epub 2020 Oct 13. PMID: 33224005; PMCID: PMC7659410. Go to original source... Go to PubMed...
    17. Bauer HW, Rahlfs VW, Lauener PA, et al. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents. 2002 Jun;19(6):451-6. doi: 10.1016/s0924-8579(02)00106-1. PMID: 12135831. Go to original source... Go to PubMed...
    18. Aziminia N, Hadjipavlou M, Philippou Y, et al. Vaccines for the prevention of recurrent urinary tract infections: a systematic review. BJU Int. 2019 May;123(5):753-768. doi: 10.1111/bju.14606. Epub 2018 Dec 19. PMID: 30378242. Go to original source... Go to PubMed...
    19. Beerepoot MA, Geerlings SE, van Haarst EP, et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013 Dec;190(6):1981-9. doi: 10.1016/j.juro.2013.04.142. Epub 2013 Jul 15. PMID: 23867306. Go to original source... Go to PubMed...
    20. Bystroň J. Bakteriální imunomodulátory - současné použití v klinické praxi. Remedia. 2010;20(5):298-304.
    21. Georgescu C, Boboc F, Iancu L, et al. Imunoterapia cu autovaccinuri în infecţiile urinare cu germeni gramnegativi [Immunotherapy with autovaccines in urinary tract infections caused by gram-negative bacteria]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1982 Apr-Jun;27(2):109-19. Romanian. PMID: 7146757.
    22. Nouza K. Systémová enzymoterapie v urologické praxi. Urol. praxi. 2012;13(5):214-217.
    23. Kuz'menko AV, Kuz'menko VV, Gyaurgiev TA. [Systemic enzyme therapy for treatment of women with chronic recurrent bacterial cystitis]. Urologiia. 2020 Apr;(2):35-40. Russian. PMID: 32351061.
    24. Kladenský J. Nekomplikované infekce dolních močových cest u žen - možnosti léčby a prevence. Urol. praxi. 2018;19(1):10-15. Go to original source...
    25. Wawrysiuk S, Naber K, Rechberger T, et al. Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review. Arch Gynecol Obstet. 2019 Oct;300(4):821-828. doi: 10.1007/s00404-019-05256-z. Epub 2019 Jul 26. PMID: 31350663; PMCID: PMC6759629. Go to original source... Go to PubMed...
    26. Fraile B, Alcover J, Royuela M, et al. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies. Future Microbiol. 2017 Jun;12:721-731. doi: 10.2217/fmb-2017-0015. Epub 2017 Mar 27. PMID: 28345957. Go to original source... Go to PubMed...
    27. de Servi B, Ranzini F, Piqué N. Effect of Utipro(®) (containing gelatin-xyloglucan) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study. Future Microbiol. 2016 May;11:651-8. doi: 10.2217/fmb-2016-0022. Epub 2016 Mar 29. PMID: 27022857. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.